Smart Labels, Smarter Protection: Building a Bulletproof IP Strategy Against Counterfeit Drugs
Schreiner Group combats counterfeit pharmaceuticals with NFC-enabled labels on autoinjectors, enabling real-time authentication, tamper detection, and digital integration. Their success lies in a holistic IP strategy👉 Approach to manage, protect, and leverage IP assets.: patents protect functionality and digital interactions; trademarks build trust through branding; design rights safeguard visual elements. By aligning technical innovation👉 Practical application of new ideas to create value. with legal protection and regulatory ecosystems, Schreiner ensures both market leadership and patient safety.
When Packaging Becomes a Life Saver
Counterfeit pharmaceuticals represent one of the most dangerous forms of global counterfeiting. According to the World Health Organization, a significant share of medicines sold in developing countries are counterfeit, and even highly regulated markets such as the EU and the US are not immune to the threat. These counterfeit drugs can result in treatment failure, drug resistance, and, in the worst cases, death.
The Schreiner Group, a German-based leader in innovative labeling technologies, has tackled this issue head-on. They developed a solution that embeds Near Field Communication (NFC) technology into the packaging of medical autoinjectors. This turns the packaging itself into a smart verification tool, enabling patients and healthcare providers to authenticate medical products instantly using smartphones.
However, Schreiner’s achievement isn’t solely technological. Their true competitive edge lies in how they’ve protected their innovation through a well-thought-out intellectual property👉 Creations of the mind protected by legal rights. (IP) strategy. This case explores how Schreiner combined patents, trademarks, and design rights into a coherent IP framework to support and secure their NFC-based anti-counterfeiting👉 Strategies to detect, prevent, and respond to IP rights infringement by fakes. technology.
Understanding the Technology: NFC Labels for Autoinjectors
Schreiner’s innovation centers around integrating NFC tags into the labels of autoinjectors—a self-administration medical device commonly used by patients for chronic diseases such as diabetes and rheumatoid arthritis. The NFC tag, embedded within the label, serves multiple functions.
Most importantly, it allows for dynamic authentication. Patients or pharmacists can scan the label using an NFC-enabled smartphone to verify whether the product is genuine. The response is cryptographically secured, making it virtually impossible for counterfeiters to replicate. In addition, these tags can store product-specific data such as expiry dates, batch numbers, and even usage instructions, effectively turning the label into an intelligent companion for the patient.
The label can also detect and record tampering. If the packaging is opened or compromised, the tag registers the event and can signal the breach during subsequent scans. This offers a real-time integrity check throughout the product’s lifecycle.
While this solution significantly raises the bar in pharmaceutical security, the bigger question arises: How does Schreiner Group protect its innovation from being copied or reverse engineered?
The IP Challenge: Securing a Multidimensional Innovation
Schreiner’s solution operates at the intersection of hardware, software, and user experience. Traditional IP protections—such as patents—are typically structured to safeguard mechanical inventions👉 A novel method, process or product that is original and useful. or chemical compositions. But in Schreiner’s case, the innovation is multifaceted: it’s a physical label, a digital interface, and a component of a connected health ecosystem.
The challenge, therefore, is to develop an IP strategy that recognizes and protects each of these elements. Schreiner’s approach consists of three pillars: patent👉 A legal right granting exclusive control over an invention for a limited time. protection for the technology, trademark👉 A distinctive sign identifying goods or services from a specific source. protection for the brand👉 A distinctive identity that differentiates a product, service, or entity. and consumer trust elements, and design protection for the physical and aesthetic components of the label.
Patents: Defending the Functional Core
At the heart of Schreiner’s IP portfolio is Patent US 12,153,981 B2 (WO2020/200706), which covers the integration of RFID or NFC tags into the secondary packaging of medical devices, specifically autoinjectors. This patent doesn’t just describe the use of NFC technology in labels—it outlines how the tag is embedded in the packaging, what kind of data it stores, how it interacts with user devices, and how it fits into a larger digital health ecosystem.
This is a strategic move. By patenting not just the label itself but also the functional interactions it supports—such as data exchange with mobile apps and integration into cloud-based monitoring platforms—Schreiner ensures that any competing solution must significantly diverge in both form and function.
Moreover, the patent protects the method and system, not just the product. This is important in IP strategy because it allows Schreiner to pursue infringers who might try to copy the concept using slightly altered materials or tag placements.
A robust patent also deters potential infringers and increases Schreiner’s value in the eyes of partners, regulators, and customers. It signals that the company controls a vital piece of technology that is both technically sound and legally protected.
Trademarks: Creating a Trustworthy User Experience
Trademarks play a different but equally important role in Schreiner’s IP strategy. The company recognizes that technical protection alone is not enough—trust must be earned and maintained at the consumer level.
To that end, Schreiner developed distinctive branding elements for its NFC-based solutions. By applying for trademarks that go beyond logos and extend into what’s known as “ingredient branding,” they effectively market the presence of the NFC label itself as a sign of quality. Just as Intel’s “Intel Inside” became synonymous with trustworthy computing, Schreiner’s branded NFC labels become a visible signal of authenticity in pharmaceuticals.
These trademarks allow Schreiner to retain exclusive rights over the appearance and representation of their technology in the marketplace. Even if a competitor develops a similar technology, they cannot legally market it using the same symbols or terminology that Schreiner has trademarked.
Branding is especially powerful in pharma, where packaging is often the last line of defence against counterfeit products. If consumers learn to trust Schreiner’s NFC label as a mark of safety, the brand equity👉 The added value a brand creates through recognition, trust, and loyalty. becomes as valuable as the underlying technology.
Design Rights: Securing the Visual Identity
While patents cover function and trademarks protect brand identity, design rights provide a third layer of protection focused on form and appearance. In Schreiner’s case, design protection extends to the layout of the NFC chip, the visual aesthetics of the label, and the unique appearance of the autoinjector packaging.
This protection is critical because it prevents competitors from producing lookalike products that mimic Schreiner’s innovation visually without infringing on its patents. Design rights are especially useful in jurisdictions where patent litigation is slow or enforcement is weak.
Moreover, they can often be secured more quickly than patents and require less technical detail, providing a faster path to enforceable rights.
Beyond IP: Integrating Technical and Non-Technical Measures
While Schreiner has constructed a strong IP framework, the company also recognizes that IP alone cannot fight counterfeiting. A comprehensive anti-counterfeiting strategy includes both technical and non-technical components.
One of the most powerful synergies comes from integrating Schreiner’s NFC tags with mobile authentication apps. These apps allow users to scan and authenticate products in real-time, while also collecting usage data that can help manufacturers and regulators monitor product movement and detect irregularities.
Government support and regulatory frameworks further amplify Schreiner’s strategy. In some regions, digital verification technologies are now mandated or strongly recommended, giving companies like Schreiner a head start in compliance.
Finally, Schreiner emphasizes stakeholder collaboration. By sharing data with regulatory bodies, law enforcement, and supply chain partners, they contribute to a broader ecosystem of traceability and enforcement. This cooperative model strengthens the value of their technology and reinforces their market leadership.
Strategic Insights: What Makes Schreiner’s IP Approach Stand Out
Schreiner’s strategy offers several key takeaways for innovators developing anti-counterfeiting solutions in regulated industries:
- Holistic IP Coverage
Schreiner Group doesn’t rely solely on patents to safeguard its NFC-based labeling innovation. Instead, it strategically combines patents, trademarks, and design rights to create a multilayered protection framework. This comprehensive coverage makes it difficult for competitors to replicate their solution without infringing on at least one form of IP. - Functional Integration
The core patent extends beyond the physical label to include the broader digital interactions it enables, such as authentication via mobile devices and integration with digital health platforms. By protecting not just the product but the system in which it operates, Schreiner ensures its solution is difficult to imitate without infringing. This functional breadth gives the company leverage in both product development and legal enforcement. - Brand as a Trust Enabler
Trademarks help Schreiner convert its technical advantage into consumer trust by branding the NFC label as a recognizable quality feature. The use of ingredient branding allows the NFC label to serve as a value proposition in itself, adding perceived security to the medical product. Over time, this brand recognition can become a competitive moat that is independent of the underlying technology. - Visual Protection
Design rights allow Schreiner to protect the unique aesthetic and structural elements of its NFC labels and autoinjector packaging. These rights are particularly useful for preventing lookalike products that might mislead consumers even if the internal technology differs. This form of IP is especially valuable in regions where enforcement of functional patents is slow or uncertain. - Ecosystem Thinking
Rather than isolating its solution, Schreiner integrates it into a broader ecosystem involving mobile apps, regulatory frameworks, and supply chain partners. This systemic approach not only strengthens the product’s effectiveness but also enhances its legal and commercial defensibility. By contributing to a collaborative and traceable supply chain, Schreiner increases the overall value of its IP assets.
Conclusion: Protecting Trust, One Label at a Time
In a world where the packaging of a medicine can be the difference between life and death, Schreiner Group has demonstrated that true innovation lies not just in inventing secure technologies but in securing them—legally, strategically, and holistically.
Their NFC-based autoinjector labels are more than just technical marvels. They are testaments to the power of a well-structured IP strategy—one that protects users, preserves company value, and contributes to a safer, smarter pharmaceutical industry.
As the pharmaceutical world continues to digitalize, the Schreiner case shows that success will belong not just to those who innovate first, but to those who protect smartly and build for scale.
